Introduced to the market in 2005, Byetta treats those with type II diabetes. But in 2007, researchers found a potential link to an increased risk of acute pancreatitis and changes in kidney functions. Despite the links, doctors continue to...
Byetta Pancreatic Cancer Lawsuit Lawyer
Medication manufacturer Amylin Pharmaceuticals Inc. faces hundreds of lawsuits after reports linked its diabetes drug Byetta to a significantly increased risk of pancreatitis and pancreatic cancer. The manufacturers of other comparable Type 2...
California Atripla Lawsuits To Be Combined Into One Court Action
A California judge has combined all Atripla lawsuits against Gilead Sciences, Inc., concerning its tenofovir disoproxil fumarate (TDF) medications. The lawsuits will be coordinated as a single action to allow efficient adjudication in the...